19, 545, 591 Maida, A
This review systematically examines the varied effects of GLP-1RAs on the risk of different types of tumors, including overall cancer risk and specific cancers such as thyroid, pancreatic, reproductive system, liver, and colorectal cancers
author, Raising Body-Confident Kids and My One-Of A-Kind Body: The Ultimate Guide to Caring for Me Angela Corral, senior editor, KQEDs The California Report
Anifrolumab, a mAb that binds to IFNAR and inhibits the activity of all type-I IFNs by blocking their binding, is the sole anti-IFN therapy that have undergone Phase III randomized controlled trials (RCTs) (94, 131)
Blood Sugar Fluctuations and Their Contribution to Hot Flashes in Menopausal Women, Diabetes Care Journal